Ron Van Schaik

16PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|Apr 24, 2026
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.

|Feb 26, 2026
Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

W W A van den Broek, Jaouad Azzahhafi, Qiu Ying F van de Pol

|Mar 14, 2025
Pharmacokinetics of betamethasone in pre-eclampsia: An in vivo and ex vivo study.

Sam Schoenmakers, Letao Li, Anna C M Kluivers

|Jan 27, 2025
Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase.

Ipek Suzer Gamli, Anne Van Veggel, Rabia Sevcan Karaaslan

|Nov 13, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Wout Willem Antoon van den Broek, Jaouad Azzahhafi, Dean R P P Chan Pin Yin

Pageof 3

Frequent Collaborators

6 joint publications

Ron H J Mathijssen

3 joint publications

Anne-Marie C Dingemans

3 joint publications

Jesse J Swen

3 joint publications

Niels Heersche